title: [The management of stage I lymphomas of the T-cell type].
abstract: Between 1980 and 1988, we treated 68 patients with clinical stage I non-Hodgkin lymphomas. Fifteen patients had lesions classified as T-cell type lymphomas, and the remainder as B-cell type lymphomas. The actuarial 5-year survival rate was 42% for patients with T-cell type and 78% for patients with B-cell (p less than 0.03), and freedom from relapse was 25% and 67%, respectively (p less than 0.01). The main relapse sites for patients with T-cell type were extranodal (5 patients) and multiple sites (2 patients). These results suggest that patients with T-cell type lymphomas should be treated by aggressive combination chemotherapy as well as radiotherapy, even though their disease may appear to be limited to one region.
authors.affiliation: Department of Radiology, Saga Medical University.
authors.forename: N
authors.initials: N
authors.lastname: Hayabuchi
authors.forename: T
authors.initials: T
authors.lastname: Kishikawa
authors.forename: K
authors.initials: K
authors.lastname: Jingu
authors.forename: M
authors.initials: M
authors.lastname: Miyoshi
authors.forename: K
authors.initials: K
authors.lastname: Masuda
mesh_terms: D005260:Female; D006801:Humans; D016399:Lymphoma, T-Cell / Q000453:epidemiology / Q000401:mortality / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D015996:Survival Rate